• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$13.70 -$0.07 (-0.51%)

REAL-TIME: Last trade at

Emergent BioSolutions

NYSE:EBS

Get Ready for the Bounce

Down 24%, but Not Nuked Yet

Is Emergent BioSolutions the Perfect Stock?

Wall Street Is Seriously Discounting This Biotech Micro Cap

Emergent BioSolutions Shares Popped: What You Need to Know

Emergent BioSolutions Earnings Preview

3 Stocks Near 52-Week Lows Worth Buying

Get Ready for the Bounce

Bearish MACD for Emergent BioSolutions - Tale of the Tape

US Stock Futures: HOT STOCKS TO WATCH

Abbott To End Development Deal With Emergent On Cancer Drug

US Stock Futures: HOT STOCKS TO WATCH

Biotech Post-Holiday Regifting

The Highest-Rated Biotech Stocks

The 8 Highest Potential Returns in Biotechnology

Whoa! My Stock Just Whomped the Market!

Emergent BioSolutions Shares Jumped: What You Need to Know

5-Star Stocks Poised to Pop: Emergent BioSolutions

Emergent BioSolutions' CEO Discusses Q2 2011 Results - Earnings Call Transcript

Investors Cheer Probable Government Contract For Emergent Vaccine

Emergent BioSolutions CEO Discusses Q1 2011 Results - Earnings Call Transcript

Emergent BioSolutions CEO Discusses Q1 2011 Results - Earnings Call Transcript

Top 15 Most Undervalued Biotech Stocks By Analyst Target Price

10 Stocks That Bucked This Week's Sell-Off

10 Stocks That Bucked This Week's Selloff

6 Biotech Firms With Encouraging DuPont Breakdowns

Emergent BioSolutions CEO Discusses Q4 2010 Results - Earnings Call Transcript

Emergent BioSolutions CEO Discusses Q4 2010 Results - Earnings Call Transcript

5 Undervalued Biotech Stocks for Your Watchlist

Are Inflation Fears Driving Bond Money to Equities?

The Top Management Teams in the Biotech Industry

Stocks With the Most Up Days in December

20 Historically Profitable Companies Hitting New Highs

The Few, The Proud: Up Post Lehman and Up Post Low

15 Top Management Teams Hitting New Highs

3 Insider Stocks That Could Pop

The 20 Most Undervalued Biotech Stocks

Emergent BioSolutions CEO Discusses Q3 2010 Results – Earnings Call Transcript

Emergent BioSolutions CEO Discusses Q3 2010 Results – Earnings Call Transcript

Why Pharmathene Could Go From $2 to $20

See More Articles...